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ABSTRACT
Objective: To identify the rate and prognosis of retinopathy of prematurity (ROP) among
newborn infants of birthweight of above 1500 grams, and the possible risk factors associated
with the disease.
Design: A prospective cohort study.
Setting: Neonatal unit at Maternity Hospital, Kuwait city, Kuwait.
Methods: All low birth weight infants were examined for the presence of ROP in the period
between January 1996 to December 1997. Prospective collection of data on babies who were
above 1500 grams was done to find an association between the disease in these babies and
some of the maternal and neonatal risk factors.
Results: A total of 68 babies of birth weight above 1500 grams were screened for ROP out of
which 13 (19.1%) had different stages of the disease. None of the patients had threshold
disease requiring surgery. Among the risk factors chosen, oxygen therapy, presence of
hypotension at birth and the non-use of surfactant were the only risk factors to be associated
with disease. However, with logistic regression analysis, none of these were independently
associated with ROP.
Conclusion: ROP may occur in newborn infants of larger birthweight but with good
prognosis, and oxygen therapy seems to predispose to the disease.
INTRODUCTION
Retinopathy of prematurity (ROP) is a disorder of
blood vessels in the developing retina of the premature
infants(1-3), and is one of the important causes of blindness
and impaired vision among children(2,4). The incidence
varies in different neonatal units(5-7) and low birth weight
has been the only risk factor uniformly identified(5-14).
However, the disease may occur in the larger birth weight
babies but with no information about the prognosis and the
risk factors associated with it(10,15). We report the
incidence of ROP in a cohort of babies of birth weight
above 1500 grams with the possible risk factors and the
prognosis of the disease in this group of babies.
MATERIALS AND METHODS
We screened all infants admitted to the neonatal unit at
Maternity Hospital and of gestational age below 34 weeks in the
period between January 1996 and December 1997. The screening
was performed by the ophthalmologist using indirect
ophthalmoscope after dilating the pupils of the babies by 2.5%
phenylephrine and 0.5% tropicamide eye drops instilled into
each eye three times at intervals of 15 minutes prior to examination.
We followed the protocol of examining preterm infants at four
weeks of postnatal age and/or at 32 weeks corrected age, and
those above 32 weeks gestation were examined in the first week
of birth. If no ROP was detected at the initial examination, the
infants were re-evaluated once every two weeks until discharge
and then every four weeks until three months of corrected age. If
ROP was detected, the examinations were performed every
week till the disease started to regress. The changes of ROP were
classified according to the International Classification of
Retinopathy of Prematurity(14).
The data of patients were collected prospectively. The
following neonatal risk factors were considered: birth weight,
gestational age, Apgar score of less than 5 at five minutes and
oxygen therapy which was defined as the maximum fractional
inspired oxygen (FiO2) needed by the baby to keep the oxygen
saturation above 91% for more than 24 hours. In addition,
surfactant therapy (Survanta®); presence of anaemia or
hypotension at birth and reception of blood transfusion in the
first 24 hours, the total number of blood transfusions received
during the hospital stay, phototherapy, total parentral nutrition,
presence of patent ductus arteriosus, intraventricular
haemorrhage, apnoea, proven sepsis and undergoing abdominal
surgery were also considered.
Furthermore, the following maternal risk factors were also
considered: gestational or maternal diabetes, gestational or
maternal hypertension, antepartum haemorrhage, chorio-
amnionitis and premature rupture of membranes. The data were
then entered in the SSPS database software and analysed
statistically using Student t-test for continuous variables and
Chi-square test for categorical variables(16). Stepwise logistic
regression analysis was used to determine the predictors associated
with the development of the disease(17).
RESULTS
Three hundreds and two babies were screened for ROP
over the two years out of which sixty eight were of birth
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weight above 1500 grams. The mean birth weight was
1768±188.5 grams (range 1530-2460). There were 41 males
and 27 females, 40 singletons, eight sets of twins and four
sets of triplets. There were no deaths. The overall number
of documented ROP among all babies in our unit is 164
(54.3%). In those above 1500 grams the total number was
13 (19.1%), and in all the disease was in both eyes. Two of
the cases were of stage three but did not reach threshold
point and the disease has regressed. Among the risk factors
defined only maximum fractional inspired oxygen (FiO2),
presence of hypotension at birth and the non-use of surfactant
were significantly associated with the disease.
Table 1
Neonatal risk factors associated with ROP
ROP (n=13) No ROP (n=55) p value
Birth weight in grams 1695.4±164 1785±213 0.16
Mean ± SD
Oxygen FiO2 (%) 50.38±11.08 43.09±8.02 0.008
Mean ± SD
Presence of patent
ductus arteriosus 4 (30.8%) 6 (11 %) 0.09
Presence of intra-
ventricular hemorrhage 1 (7.7%) 4 (7.3%) 0.67
Blood transfusion in the
first 24 hours 4 (30.8%) 6 (11%) 0.09
Surfactant therapy 5 (38.5%) 6 (11%) 0.03
Phototherapy 9 (69.2%) 22 (40%) 0.055
Apnoea 3 (23%) 5 (9.1 %) 0.17
Apgar score < 5 at 5 min 3 (23%) 14 (25.5%) 0.58
Proven sepsis 4 (30.8%) 6 (8.8%) 0.09
Undergone surgery 1 (7.7%) 1 (1.8%) 0.35
Total parentral nutrition 6 (46.2%) 16 (29.1%) 0.2
Number of blood
transfusion (mean±SD) 1.85±2.51  0.91±1.87 0.13
Presence of anemia at birth 3 (23%) 7 (12.7%) 0.39
Presence of hypotension
at birth 4 (30.8%) 4 (7.3%) 0.038
Table 2
Maternal risk factors associated with ROP
ROP (n=13) No ROP (n=55) p value
Antepartum haemorrhage 2 (15.4%) 7 (12.7%) 0.55
Chorioamnionitis 1 (7.7%) 1 (1.8%) 0.8
Gestational diabetes 2 (15.4%) 4 (7.3%) 0.67
Maternal hypertension 1 (7.7%) 14 (25.5%) 0.15
Premature rupture of
membranes 5 (38.5%) 5 (9.1%) 0.33
Tables 1 and 2 respectively show the neonatal and maternal
risk factors associated with the disease. After stepwise
logistic regression analysis none of these factors was an
independent predictor of the disease.
DISCUSSION
Retinopathy of prematurity is the disease of low birth
weight as it is the definite risk factor established in all
studies of this matter(1,4-8,14). Neonatal units have
different prevalence of the disease. This possibly depends
on the examining ophthalmologist in identifying the disease
and its stages and the guidelines for screening and
treatment(18).
Our disease prevalence was 54.3% which is different
from some of the units in the region; in Oman is 34%, and
in a centre in India was 20%(5,6). However, none of these
centres reported the prevalence of the disease in those
babies above 1500 grams. Jandeck et al(15) reported the
occurrence of ROP in three babies of birth weight above
2000 grams after haemorrhagic shock. In their study, they
screened 123 babies of above 1500 grams and apart from
the three shocked babies, none of the rest developed any
stage of the disease. One of the three babies required
cryotherapy after the disease reached a threshold stage. No
other risk factors were identified to be associated with the
disease and they concluded that severe haemorrhagic
shock could be a risk factor for the development of ROP
even in large babies. Our study reported the occurrence of
the disease in the babies of birth weight above 1500 grams
in a rate of 19.1%, but none of them reached threshold
stage and all have the disease regressed(19). No risk
factors were independently associated with the disease
although oxygen therapy tended to be a likely risk factor.
We did not have any baby who was exposed to severe
circulatory shock. Holmstrom et al(11) assessed maternal
risk factors associated with ROPI. They found That
essential hypertension prior to pregnancy was a predicting
risk factor. In our study, a univariate analysis of the
maternal risk factors revealed that none was associated
with the ROP although our babies were larger in weight.
So we concluded that ROP does occur in babies of
birth weight more than 1500 grams but in mild form and
with good prognosis, and screening in this group of babies
is not warranted and should be limited to very low and the
extremely low birth weight babies.
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Letter to the Editor-in-Chief
Dear Sir,
RE: THE VERY HIGH MATERNAL MORTALITY RATIOS: HOW REAL?
Maternal mortality ratio is a proxy for the more accurate maternal
mortality rate, since measuring all pregnancies in a population, as
expected in maternal mortality rate is neither feasible nor practicable.
Maternal mortality ratio is calculated by dividing the number of
maternal deaths regardless of pregnancy outcome (ectopic pregnancy,
foetal deaths, livebirths) by the number of livebirths in a defined
population(1).
Institution-based maternal mortality ratios, especially from the
developing countries appear to be scandalously high(2-5). Is this a true
reflection of events or some statistical artifact?
A few salient points might provide the correct answer. For instance,
it is common practice in some parts of Nigeria for pregnant mothers to
elect home delivery even when they have had antenatal care in the
hospital. This inadvertently lowers the denominator, in the calculation
for maternal mortality ratio for the health institution.
Paradoxically, in the same community, within the same period,
some pregnant mothers might be brought to the hospital for the first time
only when they are in moribund state (at times gasping for the last
breath), following pregnancy or labour complications. To such patients,
the hospital is more of a mortuary than a maternity centre, thus increasing
the number of maternal deaths for the institution. It is therefore easy to
understand why some institutional maternal mortality ratios are high - at
times too high to be real.
There is yet another mathematical dimension to the issue. Because
of the less than satisfactory prenatal and intrapartum care that pregnant
mothers receive in most of the developing countries, there are more cases
of foetal deaths or stillbirths than what obtains in the advanced, western
nations. As a result, while live births almost approximate to total births
in the developed countries, the difference between the two in the
developing countries could be enormous. However, since maternal
mortality ratio is calculated using live births as denominator, the relatively
small live births (as opposed to total births) in the developing countries
will inevitably lead to an outrageously high maternal mortality ratio. In
fact, most authors from the developing countries would rather prefer to
calculate maternal mortality rate using total deliveries as the
denominator(6, 7) instead of livebirths, perhaps to minimise these
artifacts.
Again, let us not miss the point! In sub-Saharan Africa, the time risk
that a woman would die in childbirth is 1 in 21; which is times higher than
the lifetime risk for her counterpart in Western Europe or North America.
It is an undisputed fact that there are too many avoidable maternal deaths
in the developing or impoverished countries. My humble submission
however, is that unless we recognise some of these arithmetic errors and
statistical artifacts in institution-based maternal mortality reports,
especially those emanating from the developing countries, we might
soon conclude erroneously that there are no women of reproductive age
in the third world countries anymore, because of the toll of maternal
mortality. That we know is not true! We must therefore interpret figures
on maternal deaths from developing countries with caution.
Yours sincerely
B. Ekele, MBBS, FWACS, FICS, Senior Lecturer/Consultant Obstetrician,
Department of Obstetrics and Gynaecology, Usmanu Danfodiyo University
Teaching Hospital, Sokoto, Nigeria.
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